He also reviewed the potential for replication competent reovirus to enhance specific anti-tumour responses by making ‘cold’ tumours (low CD8+ TILs/PD-L1 expression) ‘hot’, leading to tumour regression when combined with PD-1 blockade. The gene discussed is CD274; the disease is neoplasm.